ARCHIVES

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

Cell Phone Radiation Does Not Raise Child’s Risk of Tumors

August 26, 2011

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

Prevention & Control Study Section Needed: Letter to the Editor

June 11, 1993

Test Of HHS Secretary’s Remarks On cancer Mortality Rate Findings

November 22, 1996

Pinkel Corrects Report On ALL – Two Drugs Are Better Than One

April 21, 1978